×

CPT Changes

Current book and archives back to 2000
Easy-to-read online book format
Linked to and from code details

learn more

close

Adenocarcinomas, malignant

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01

sections/codes in this section ()

• Acidophil carcinoma  (XH2QZ6)
• Adenocarcinoid tumour  (XH5LA4)
• Adenocarcinoma, NOS  (XH74S1)
• Adenocarcinoma in adenomatous polyp  (XH7QZ0)
• Adenocarcinoma in adenomatous polyposis coli  (XH2ZH8)
• Adenocarcinoma in multiple adenomatous polyps  (XH9YR3)
• Adenocarcinoma in tubulovillous adenoma  (XH7QB1)
• Adenocarcinoma in villous adenoma  (XH6DA5)
• Adenocarcinoma of anal glands  (XH5RE1)
• Adenocarcinoma with mixed subtypes  (XH2ZQ0)
• Adenocarcinoma, intestinal type  (XH0349)
• Solid carcinoma, NOS  (XH8B45)
• Neuroendocrine tumour, NOS  (XH8DS0)
• Neuroendocrine carcinoma, low grade  (XH8LX8)
• Neuroendocrine carcinoma, well-differentiated  (XH55D7)
• Neuroendocrine tumor, grade 1  (XH9LV8)
• Enterochromaffin cell carcinoid  (XH7NM1)
• Neuroendocrine carcinoma, NOS  (XH0U20)
• Neuroendocrine carcinoma, moderately differentiated  (XH7F73)
• Lepidic adenocarcinoma  (XH24W2)
• Minimally invasive adenocarcinoma, Non-mucinous  (XH3QM0)
• Adenoid cystic carcinoma  (XH4302)
• Minimally invasive adenocarcinoma, Mucinous  (XH2098)
• Papillary adenocarcinoma, NOS  (XH6LV9)
• Villoglandular carcinoma  (XH95U1)
• Micropapillary carcinoma, NOS  (XH6QG3)
• Micropapillary adenocarcinoma  (XH4MW7)
• Pituitary carcinoma, NOS  (XH7KL6)
• Clear cell adenocarcinoma, NOS  (XH6L02)
• Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma  (XH5085)
• MiT Family translocation carcinomas  (XH1442)
• Succinate dehydrogenase deficient renal cell carcinoma  (XH8EN1)
• Alveolar adenocarcinoma  (XH07X3)
• Renal cell carcinoma, NOS  (XH05V6)
• Renal cell carcinoma, unclassified  (XH3Z08)
• Acquired cystic disease associated renal cell carcinoma  (XH0RU3)
• Tubulocystic renal cell carcinoma  (XH7K79)
• Hybrid oncocytic chromophobe tumour  (XH1VB1)
• Follicular carcinoma, NOS  (XH3Z50)
• Endometrioid adenocarcinoma, ciliated cell variant  (XH9508)
• Endometrioid adenocarcinoma, secretory variant  (XH0718)
• Adrenal cortical carcinoma  (XH4KH2)
• Endometrioid adenocarcinoma, NOS  (XH0SD2)
• Neuroendocrine tumour, grade 2  (XH51K1)
• Endometrioid cystadenocarcinoma  (XH09B7)
• Endometrioid adenofibroma, malignant  (XH6KR7)
• Adenocarcinoma, endocervical type  (XH0GS9)
• Islet cell adenomatosis  (XH8SF8)
• Perihilar cholangiocarcinoma  (XH43E4)
• Islet cell adenoma  (XH4BY1)
• Villoglandular variant of endometrioid adenocarcinoma  (XH3CU4)
• Pituitary blastoma  (XH5QV8)
• Follicular carcinoma, encapsulated, angioinvasive  (XH0Y80)
• Clear cell renal cell carcinoma, NOS  (XH46F1)
• Basal cell adenocarcinoma  (XH9SA7)
• Endolymphatic sac tumor  (XH85C2)
• Acinar adenocarcinoma of prostate  (XH4PB1)
• Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)  (XH8E54)
• Neuroendocrine tumour, grade 3  (XH5QW8)
• Nesidioblastoma  (XH1NL5)
• Islet cell carcinoma  (XH5XB7)
• Islet cell tumor, NOS  (XH2ST7)
• Insulinoma, NOS  (XH4SH8)
• Gastrinoma  (XH93H8)
• Parathyroid carcinoma  (XH7JQ0)
• Basophil carcinoma  (XH9LV7)
• Glucagon-like peptide-producing tumour  (XH7152)
• L-cell tumour  (XH7LW9)
• Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumour  (XH9ZS8)
• Glucagonoma  (XH4NQ8)
• Enteroglucagonoma  (XH2PF0)
• Vipoma  (XH72E5)
• Somatostatinoma  (XH5VH0)
• Endocrine tumour, functioning, NOS  (XH41P2)
• ACTH-producing tumour  (XH7AG8)
• Medullary thyroid carcinoma  (XH60V1)
• Bile duct cystadenocarcinoma  (XH3BU6)
• Medullary carcinoma with amyloid stroma  (XH2MW1)
• Poorly differentiated thyroid carcinoma  (XH8VU6)
• Pituitary neuroendocrine tumour  (XH4NH4)
• Bronchial adenoma, carcinoid  (XH2ZA2)
• Adenocarcinoma of lung, mixed mucinous and non-mucinous  (XH5TR7)
• Adenocarcinoma of lung, mucinous  (XH7GY6)
• Bronchiolo-alveolar carcinoma, non-mucinous  (XH2035)
• Carcinoma simplex  (XH6LF9)
• Carcinoma, diffuse type  (XH0XL5)
• Cholangiocarcinoma  (XH7M15)
• Chromophobe carcinoma  (XH7SS7)
• Clear cell adenocarcinofibroma  (XH2Q13)
• Clear cell adenocarcinoma, mesonephroid  (XH6YS0)
• Collecting duct carcinoma  (XH4SQ4)
• Combined hepatocellular carcinoma and cholangiocarcinoma  (XH7QJ6)
• Cyst-associated renal cell carcinoma  (XH4KK0)
• Enterochromaffin-like cell tumour  (XH0LH8)
• Fetal adenocarcinoma  (XH5P16)
• Follicular adenocarcinoma, moderately differentiated  (XH7TE3)
• Follicular adenocarcinoma, trabecular  (XH0VD1)
• Follicular adenocarcinoma, well differentiated  (XH8FK7)
• Follicular carcinoma, minimally invasive  (XH3DN7)
• Follicular carcinoma, oxyphilic cell  (XH90N9)
• Glycogen-rich carcinoma  (XH3XT5)
• Goblet cell carcinoid  (XH4262)
• Granular cell carcinoma  (XH2EH4)
• Hepatocellular carcinoma, clear cell type  (XH4T58)
• Hepatocellular carcinoma, fibrolamellar  (XH9Q35)
• Hepatocellular carcinoma, pleomorphic type  (XH0G90)
• Hepatocellular carcinoma, scirrhous  (XH5761)
• Hepatocellular carcinoma, spindle cell variant  (XH3T17)
• Hurthle cell adenocarcinoma  (XH6YH5)
• Hurthle cell carcinoma  (XH8MQ3)
• Linitis plastica  (XH8WM4)
• Lipid-rich carcinoma  (XH6TK0)
• Merkel cell carcinoma  (XH81N8)
• Mixed acidophil-basophil carcinoma  (XH7019)
• Mixed acinar-endocrine carcinoma  (XH8EZ3)
• Mixed acinar-endocrine-ductal carcinoma  (XH74Y9)
• Mixed adenoneuroendocrine carcinoma  (XH6H10)
• Mixed cell adenocarcinoma  (XH2AM6)
• Mixed ductal-endocrine carcinoma  (XH7CY5)
• Mixed endocrine and exocrine adenocarcinoma  (XH6UP4)
• Mixed medullary-follicular carcinoma  (XH7DG7)
• Mixed medullary-papillary carcinoma  (XH3340)
• Mixed pancreatic endocrine and exocrine tumour, malignant  (XH9LZ7)
• Nonencapsulated sclerosing carcinoma  (XH1108)
• Oxyphilic adenocarcinoma  (XH09D6)
• Islet cell adenocarcinoma  (XH3614)
• Pancreatic neuroendocrine tumor, nonfunctioning  (XH3709)
• Pancreatobiliary-type carcinoma  (XH6XY9)
• Papillary carcinoma of thyroid  (XH1ND9)
• Papillary carcinoma, columnar cell  (XH85E5)
• Papillary carcinoma, diffuse sclerosing  (XH0426)
• Papillary carcinoma, encapsulated, of thyroid  (XH0Q59)
• Papillary carcinoma, follicular variant  (XH29M4)
• Papillary carcinoma, oncocytic variant  (XH5YT2)
• Papillary microcarcinoma  (XH2AW7)
• Papillary renal cell carcinoma  (XH1D07)
• Papillotubular adenocarcinoma  (XH4Q20)
• Parietal cell carcinoma  (XH1JZ0)
• Renal cell carcinoma, chromophobe type  (XH6153)
• Renal cell carcinoma, sarcomatoid  (XH9DH7)
• Scirrhous adenocarcinoma  (XH4FS4)
• Solid carcinoma with mucin formation  (XH34G3)
• Superficial spreading adenocarcinoma  (XH0JE3)
• Trabecular adenocarcinoma  (XH7EX3)
• Tubular adenocarcinoma  (XH4TA4)
• Typical carcinoid  (XH1Z69)
• Carcinoma of Skene, Cowper and Littre Glands  (XH22Z8)
• Villous adenocarcinoma  (XH0X20)
• Water-clear cell adenocarcinoma  (XH0A57)
• Adenocarcinoma, metastatic, NOS  (XH8UE4)
• Basal cell carcinoma of the prostate  (XH4ZC3)
• Hepatocellular carcinoma, NOS  (XH4W48)
• Bronchial adenoma, cylindroid  (XH81Q9)
• Thymic carcinoma with adenoid cystic carcinoma-like features  (XH92Y9)
• Cribriform carcinoma, NOS  (XH1YZ3)
• Cribriform comedo-type carcinoma  (XH4YG1)
• Serrated adenocarcinoma  (XH74B2)

Thank you for choosing Find-A-Code, please Sign In to remove ads.